Evidence map›Paper›PMID 35935998›Full record

ArticleFrontiers in immunology2022

IFN-I inducible

Françoise Vuillier, Zhi Li, Iain Black, Melania Cruciani, Erminia Rubino, Frédérique Michel, Sandra Pellegrini

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The role of ADAR1 in human pathophysiology.Frontiers in cell and developmental biology · 2025
    Review
  5. Review
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Françoise VuillierCytokine Signaling Unit, Department of Immunology, Institut Pasteur, Paris, France.
Zhi LiCytokine Signaling Unit, Department of Immunology, Institut Pasteur, Paris, France.
Iain BlackCytokine Signaling Unit, Department of Immunology, Institut Pasteur, Paris, France.
Melania CrucianiCytokine Signaling Unit, Department of Immunology, Institut Pasteur, Paris, France.
Erminia RubinoCytokine Signaling Unit, Department of Immunology, Institut Pasteur, Paris, France.
Frédérique MichelCytokine Signaling Unit, Department of Immunology, Institut Pasteur, Paris, France.
Sandra PellegriniCytokine Signaling Unit, Department of Immunology, Institut Pasteur, Paris, France.
Institut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulation of innate immune responses is essential for maintenance of immune homeostasis and development of an appropriate immunity against microbial infection. We show here that

Indexed as

Immunity, InnateInterferon Type IMicroRNAsAdenosine DeaminaseAntibodiesAntiviral AgentsHeLa CellsHumansProtein IsoformsRNA-Binding ProteinsRNA, Double-StrandedTranscription FactorsTripartite Motif ProteinsUbiquitin-Protein LigasesADAR protein, humanAdenosine DeaminaseAntibodiesAntiviral AgentsInterferon Type IMicroRNAsProtein IsoformsRNA-Binding ProteinsRNA, Double-StrandedTranscription FactorsTRIM25 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesADAR1innate responsemicroRNATRIM25type I interferon

Identifiers

PMID35935998
PMCPMC9354889
OpenAlexW4286561313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.